When will Keyuan Pharmaceutical be listed?

Keyuan Pharmaceutical was listed on April 4, 2023.

Keyuan Pharmaceutical Co., Ltd. is a national high-tech enterprise, a core member enterprise of Linuo Group's health industry and a backbone enterprise of chemical synthetic drugs. Keyuan Pharmaceutical Co., Ltd. is committed to the research and development, production and sales of chemical raw materials and the development of international high-end business. Keyuan Pharmaceutical Co., Ltd. has established strategic partnership with many internationally renowned enterprises.

Keyuan Pharmaceutical Co., Ltd. has obtained domestic GMP certificate and EU CEP certificate, and passed the international official certification of FDA, Canada, Japan and South Korea. Keyuan Pharmaceutical Co., Ltd. has a relatively complete production and research and development system. The company has provincial-level recognized enterprise technology center and municipal-level postdoctoral innovation practice base.

Internet users' comments on Keyuan Pharmaceutical.

Keyuan Pharmaceutical is an enterprise that has made great contributions to human health. Keyuan Pharmaceutical always adheres to the corporate mission of Linuo Group to serve the country and pursue Excellence. While maintaining the steady growth of the company's traditional products, we will vigorously develop CMO business and strive to promote the industrial layout of characteristic raw materials.

Keyuan Pharmaceutical Co., Ltd. continuously strengthens R&D investment and introduces automatic production lines. Keyuan Pharmaceutical has continuously strengthened the continuous optimization and development of the production technology of existing leading products. Keyuan Pharmaceutical is a domestic first-class and internationally influential company. Keyuan pharmaceutical co., ltd promotes the healthy development of human beings.